Cell senescence: A challenge in cartilage engineering and regeneration

Tissue Engineering - Part B: Reviews

Volumn 18, Issue 4, 2012, Pages 270-287

  Li, Jingting ^a   Pei, Ming ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b West Virginia University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS CHONDROCYTE IMPLANTATIONS; CARTILAGE DEFECTS; CARTILAGE ENGINEERING; CARTILAGE REGENERATION; CARTILAGE TISSUE ENGINEERING; CELL MATRIX; CELL SOURCES; CHONDROCYTES; DECELLULARIZED; DEGENERATIVE DISEASE; DNA DAMAGES; DNA REPLICATIONS; EX VIVO EXPANSION; EXTRACELLULAR MATRICES; GROWTH FACTOR; LOW OXYGEN; MESENCHYMAL STEM CELL; PLATELET RICH PLASMA; REACTIVE OXYGEN SPECIES; SERUM DEPRIVATION; SIGNALING PATHWAYS; TELOMERASE ACTIVITY; TELOMERE LENGTH;

BODY FLUIDS; CARTILAGE; CELL CULTURE; OXYGEN; PLASMA APPLICATIONS; STEM CELLS; TISSUE ENGINEERING;

CELL ENGINEERING;

ACETYLCYSTEINE; ANTIOXIDANT; BETA CATENIN; BETA GALACTOSIDASE; CCN PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FULLERENE; GLUCOSE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMAD PROTEIN; SOMATOMEDIN C; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN;

ANIMAL CELL; CARTILAGE; CARTILAGE CELL; CELL AGING; CELL DIFFERENTIATION; CELL RENEWAL; CULTURE MEDIUM; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; INTERVERTEBRAL DISK DEGENERATION; JOINT INJURY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; TISSUE REGENERATION;

ADULT; ADULT STEM CELLS; ANIMALS; CARTILAGE; CELL AGING; HUMANS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; REGENERATION; TISSUE ENGINEERING;

EID: 84864191875     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2011.0583     Document Type: Review

References (256)

1. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
2. Peterson, L., Minas, T., Brittberg, M., Nilsson, A., Sjogren- Jansson, E., and Lindahl, A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 374, 212, 2000.
3. Browne, J.E., Anderson, A.F., Arciero, R., Mandelbaum, B., Moseley, J.B., Jr., Micheli, L.J., Fu, F., and Erggelet, C. Clinical outcome of autologous chondrocyte implantation at 5 years in US subjects. Clin Orthop Relat Res 436, 237, 2005.
4. Kreuz, P.C., Steinwachs, M., Erggelet, C., Lahm, A., Krause, S., Ossendorf, C., Meier, D., Ghanem, N., and Uhl, M. Importance of sports in cartilage regeneration after autologous chondrocyte implantation: a prospective study with a 3-year follow-up. Am J Sports Med 35, 1261, 2007.
5. Mandelbaum, B., Browne, J.E., Fu, F., Micheli, L.J., Moseley, J.B., Jr., Erggelet, C., and Anderson, A.F. Treatment outcomes of autologous chondrocyte implantation for fullthickness articular cartilage defects of the trochlea. Am J Sports Med 35, 915, 2007.
6. Mithofer, K., Peterson, L., Mandelbaum, B.R., and Minas, T. Articular cartilage repair in soccer players with autologous chondrocyte transplantation: functional outcome and return to competition. Am J Sports Med 33, 1639, 2005.
7. McNickle, A.G., L'Heureux, D.R., Yanke, A.B., and Cole, B.J. Outcomes of autologous chondrocyte implantation in a diverse patient population. Am J Sports Med 37, 1344, 2009.
8. Vasiliadis, H.S., Wasiak, J., and Salanti, G. Autologous chondrocyte implantation for the treatment of cartilage lesions of the knee: a systematic review of randomized studies. Knee Surg Sports Traumatol Arthrosc 18, 1645, 2010.
9. Nakamura, N., Miyama, T., Engebretsen, L., Yoshikawa, H., and Shino, K. Cell-based therapy in articular cartilage lesions of the knee. Arthroscopy 25, 531, 2009.
10. Knutsen, G., Drogset, J.O., Engebretsen, L., Grontvedt, T., Isaksen, V., Ludvigsen, T.C., Roberts, S., Solheim, E., Strand, T., and Johansen, O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89, 2105, 2007.
11. Friedenstein, A.J., Chailakhjan, R.K., and Lalykina, K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3, 393, 1970.
12. Kafienah, W., Mistry, S., Williams, C., and Hollander, A.P. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells 24, 1113, 2006.
13. Kafienah, W., Mistry, S., Dickinson, S.C., Sims, T.J., Learmonth, I., and Hollander, A.P. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum 56, 177, 2007.
14. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
15. Seda Tigli, R., Ghosh, S., Laha, M.M., Shevde, N.K., Daheron, L., Gimble, J., Gumusderelioglu, M., and Kaplan, D.L. Comparative chondrogenesis of human cell sources in 3D scaffolds. J Tissue Eng Regen Med 3, 348, 2009.
16. Sefcik, L.S., Neal, R.A., Kaszuba, S.N., Parker, A.M., Katz, A.J., Ogle, R.C., and Botchwey, E.A. Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic differentiation of human adipose stem cells. J Tissue Eng Regen Med 2, 210, 2008.
17. Lin, J., Lindsey, M.L., Zhu, B., Agrawal, C.M., and Bailey, S.R. Effects of surface-modified scaffolds on the growth and differentiation of mouse adipose-derived stromal cells. J Tissue Eng Regen Med 1, 211, 2007.
18. Fraser, J.K., Wulur, I., Alfonso, Z., and Hedrick, M.H. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24, 150, 2006.
19. Fan, J., Varshney, R.R., Ren, L., Cai, D., and Wang, D.A. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 15, 75, 2009.
20. Sakaguchi, Y., Sekiya, I., Yagishita, K., and Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52, 2521, 2005.
21. Pei, M., He, F., and Vunjak-Novakovic, G. Synoviumderived stem cell-based chondrogenesis. Differentiation 76, 1044, 2008.
22. Ando, W., Tateishi, K., Katakai, D., Hart, D.A., Higuchi, C., Nakata, K., Hashimoto, J., Fujie, H., Shino, K., Yoshikawa, H., and Nakamura, N. In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential. Tissue Eng Part A 14, 2041, 2008.
23. De Bari, C., Dell'Accio, F., Tylzanowski, P., and Luyten, F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44, 1928, 2001.
24. Ando, W., Tateishi, K., Hart, D.A., Katakai, D., Tanaka, Y., Nakata, K., Hashimoto, J., Fujie, H., Shino, K., Yoshikawa, H., and Nakamura, N. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28, 5462, 2007.
25. Park, S., Cho, H., Gil, E.S., Mandal, B., Min, B.H., and Kaplan, D.L. Silk-fibrin/hyaluronic acid composite gels for nucleus pulposus (NP) tissue regeneration. Tissue Eng Part A 17, 2999, 2011.
26. Chen, S., Emery, S.E., and Pei, M. Coculture of synoviumderived stem cells and nucleus pulposus cells in serum-free defined medium with supplementation of transforming growth factor-beta1: a potential application of tissuespecific stem cells in disc regeneration. Spine (Phila Pa 1976) 34, 1272, 2009.
27. Tan, Y., Zhang, Y., and Pei, M. Meniscus reconstruction through coculturing meniscus cells with synovium-derived stem cells on small intestine submucosa-a pilot study to engineer meniscus tissue constructs. Tissue Eng Part A 16, 67, 2010.
28. Nejadnik, H., Hui, J.H., Feng Choong, E.P., Tai, B.C., and Lee, E.H. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 38, 1110, 2010.
29. Schnabel, M., Marlovits, S., Eckhoff, G., Fichtel, I., Gotzen, L., Vecsei, V., and Schlegel, J. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 10, 62, 2002.
30. Li, Z., Liu, C., Xie, Z., Song, P., Zhao, R.C., Guo, L., Liu, Z., and Wu, Y. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6, e20526, 2011.
31. Hayflick, L. The limited in vitro Lifetime of human diploid cell strains. Exp Cell Res 37, 614, 1965.
32. Martin, J.A., and Buckwalter, J.A. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am 85-A Suppl 2, 106, 2003.
33. Tchkonia, T., Morbeck, D.E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M.D., and Kirkland, J.L. Fat tissue, aging, and cellular senescence. Aging Cell 9, 667, 2010.
34. Martin, J.A., and Buckwalter, J.A. Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol A Biol Sci Med Sci 56, B172, 2001.
35. Parsch, D., Brummendorf, T.H., Richter, W., and Fellenberg, J. Replicative aging of human articular chondrocytes during ex vivo expansion. Arthritis Rheum 46, 2911, 2002.
36. Parsch, D., Fellenberg, J., Brummendorf, T.H., Eschlbeck, A.M., and Richter, W. Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med (Berl) 82, 49, 2004.
37. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., and Ho, A.D. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3, e2213, 2008.
38. Bonab, M.M., Alimoghaddam, K., Talebian, F., Ghaffari, S.H., Ghavamzadeh, A., and Nikbin, B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7, 14, 2006.
39. Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J.M., and Lee, T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205, 194, 2005.
40. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28, 707, 2000.
41. Chen, J., Sotome, S., Wang, J., Orii, H., Uemura, T., and Shinomiya, K. Correlation of in vivo bone formation capability and in vitro differentiation of human bone marrow stromal cells. J Med Dent Sci 52, 27, 2005.
42. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
43. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7), 1161, 2000.
44. Neuhuber, B., Swanger, S.A., Howard, L., Mackay, A., and Fischer, I. Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36, 1176, 2008.
45. Digirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
46. Colter, D.C., Class, R., DiGirolamo, C.M., and Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97, 3213, 2000.
47. Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.G., and Prockop, D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530, 2002.
48. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
49. Reyes, M., and Verfaillie, C.M. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 938, 231, 2001.
50. Barbero, A., Grogan, S., Schafer, D., Heberer, M., Mainil- Varlet, P., and Martin, I. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage 12, 476, 2004.
51. Pestka, J.M., Schmal, H., Salzmann, G., Hecky, J., Sudkamp, N.P., and Niemeyer, P. In vitro cell quality of articular chondrocytes assigned for autologous implantation in dependence of specific patient characteristics. Arch Orthop Trauma Surg 131, 779, 2011.
52. Adkisson, H.D.,4th, Martin, J.A., Amendola, R.L., Milliman, C., Mauch, K.A., Katwal, A.B., Seyedin, M., Amendola, A., Streeter, P.R., and Buckwalter, J.A. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med 38, 1324, 2010.
53. Bergman, R.J., Gazit, D., Kahn, A.J., Gruber, H., McDougall, S., and Hahn, T.J. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 11, 568, 1996.
54. Bellows, C.G., Pei, W., Jia, Y., and Heersche, J.N. Proliferation, differentiation and self-renewal of osteopro- genitors in vertebral cell populations from aged and young female rats. Mech Ageing Dev 124, 747, 2003.
55. Tokalov, S.V., Gruener, S., Schindler, S., Iagunov, A.S., Baumann, M., and Abolmaali, N.D. A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol Cells 24, 255, 2007.
56. Tokalov, S.V., Gruner, S., Schindler, S., Wolf, G., Baumann, M., and Abolmaali, N. Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev 16, 439, 2007.
57. Stenderup, K., Justesen, J., Clausen, C., and Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919, 2003.
58. Mareschi, K., Ferrero, I., Rustichelli, D., Aschero, S., Gammaitoni, L., Aglietta, M., Madon, E., and Fagioli, F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97, 744, 2006.
59. Justesen, J., Stenderup, K., Eriksen, E.F., and Kassem, M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 71, 36, 2002.
60. Leskela, H.V., Risteli, J., Niskanen, S., Koivunen, J., Ivaska, K.K., and Lehenkari, P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311, 1008, 2003.
61. Stenderup, K., Justesen, J., Eriksen, E.F., Rattan, S.I., and Kassem, M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 16, 1120, 2001.
62. Scharstuhl, A., Schewe, B., Benz, K., Gaissmaier, C., Buhring, H.J., and Stoop, R. Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells 25, 3244, 2007.
63. Kretlow, J.D., Jin, Y.Q., Liu, W., Zhang, W.J., Hong, T.H., Zhou, G., Baggett, L.S., Mikos, A.G., and Cao, Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 9, 60, 2008.
64. Zheng, H., Martin, J.A., Duwayri, Y., Falcon, G., and Buckwalter, J.A. Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J Gerontol A Biol Sci Med Sci 62, 136, 2007.
65. Erickson, I.E., van Veen, S.C., Sengupta, S., Kestle, S.R., and Mauck, R.L. Cartilage matrix formation by bovine mesenchymal stem cells in three-dimensional culture is agedependent. Clin Orthop Relat Res 469, 2744, 2011.
66. Payne,K.A., Didiano, D.M., and Chu, C.R. Donor sex and age influence the chondrogenic potential of human femoral bone marrow stem cells. Osteoarthritis Cartilage 18, 705, 2010.
67. O'Driscoll, S.W. Articular cartilage regeneration using periosteum. Clin Orthop Relat Res (367 Suppl), S186, 1999.
68. De Bari, C., Dell'Accio, F., and Luyten, F.P. Human periosteum- derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44, 85, 2001.
69. Martin, J.A., Brown, T.D., Heiner, A.D., and Buckwalter, J.A. Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res (427 Suppl), S96, 2004.
70. Brandl, A., Meyer, M., Bechmann, V., Nerlich, M., and Angele, P. Oxidative stress induces senescence in human mesenchymal stem cells. Exp Cell Res 317, 1541, 2011.
71. Hong, E.H., Lee, S.J., Kim, J.S., Lee, K.H., Um, H.D., Kim, J.H., Kim, S.J., Kim, J.I., and Hwang, S.G. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem 285, 1283, 2010.
72. Hekimi, S., and Guarente, L. Genetics and the specificity of the aging process. Science 299, 1351, 2003.
73. Goldring, M.B., and Goldring, S.R. Osteoarthritis. J Cell Physiol 213, 626, 2007.
74. Koelling, S., and Miosge, N. Stem cell therapy for cartilage regeneration in osteoarthritis. Expert Opin Biol Ther 9, 1399, 2009.
75. Mobasheri, A., Csaki, C., Clutterbuck, A.L., Rahmanzadeh, M., and Shakibaei, M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Histol Histopathol 24, 347, 2009.
76. An, H.S., Anderson, P.A., Haughton, V.M., Iatridis, J.C., Kang, J.D., Lotz, J.C., Natarajan, R.N., Oegema, T.R., Jr., Roughley, P., Setton, L.A., Urban, J.P., Videman, T., Andersson, G.B., and Weinstein, J.N. Introduction: disc degeneration: summary. Spine (Phila Pa 1976) 29, 2677, 2004.
77. Murphy, J.M., Dixon, K., Beck, S., Fabian, D., Feldman, A., and Barry, F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 46, 704, 2002.
78. Han, H.S., Lee, S., Kim, J.H., Seong, S.C., and Lee, M.C. Changes in chondrogenic phenotype and gene expression profiles associated with the in vitro expansion of human synovium-derived cells. J Orthop Res 28, 1283, 2010.
79. Gruber, H.E., Ingram, J.A., Norton, H.J., and Hanley, E.N., Jr. Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine (Phila Pa 1976) 32, 321, 2007.
80. Roberts, S., Evans, E.H., Kletsas, D., Jaffray, D.C., and Eisenstein, S.M. Senescence in human intervertebral discs. Eur Spine J 15 Suppl 3, S312, 2006.
81. Le Maitre, C.L., Freemont, A.J., and Hoyland, J.A. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 9, R45, 2007.
82. Kim, K.W., Chung, H.N., Ha, K.Y., Lee, J.S., and Kim, Y.Y. Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs. Spine J 9, 658, 2009.
83. Korecki, C.L., Kuo, C.K., Tuan, R.S., and Iatridis, J.C. Intervertebral disc cell response to dynamic compression is age and frequency dependent. J Orthop Res 27, 800, 2009.
84. Dimri, G.P., Testori, A., Acosta, M., and Campisi, J. Replicative senescence, aging and growth-regulatory transcription factors. Biol Signals 5, 154, 1996.
85. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., and Pereira-Smith, O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363, 1995.
86. Chen, Q., Fischer, A., Reagan, J.D., Yan, L.J., and Ames, B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 92, 4337, 1995.
87. Song, Y.S., Lee, B.Y., and Hwang, E.S. Dinstinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis. Mech Ageing Dev 126, 580, 2005.
88. Zhou, S., Greenberger, J.S., Epperly, M.W., Goff, J.P., Adler, C., Leboff, M.S., and Glowacki, J. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7, 335, 2008.
89. Lee, B.Y., Han, J.A., Im, J.S., Morrone, A., Johung, K., Goodwin, E.C., Kleijer, W.J., DiMaio, D., and Hwang, E.S. Senescence-associated beta-galactosidase is lysosomal betagalactosidase. Aging Cell 5, 187, 2006.
90. Debacq-Chainiaux, F., Erusalimsky, J.D., Campisi, J., and Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4, 1798, 2009.
91. Whaley-Connell, A., McCullough, P.A., and Sowers, J.R. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 12, 21, 2011.
92. Carlo, M.D., Jr., and Loeser, R.F. Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum 48, 3419, 2003.
93. Hiran, T.S., Moulton, P.J., and Hancock, J.T. Detection of superoxide and NADPH oxidase in porcine articular chondrocytes. Free Radic Biol Med 23, 736, 1997.
94. Tiku, M.L., Shah, R., and Allison, G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 275, 20069, 2000.
95. Heo, J.Y., Jing, K., Song, K.S., Seo, K.S., Park, J.H., Kim, J.S., Jung, Y.J., Hur, G.M., Jo, D.Y., Kweon, G.R., Yoon, W.H., Lim, K., Hwang, B.D., Jeon, B.H., and Park, J.I. Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells. Stem Cells 27, 1455, 2009.
96. Studer, R., Jaffurs, D., Stefanovic-Racic, M., Robbins, P.D., and Evans, C.H. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 7, 377, 1999.
97. Jallali, N., Ridha, H., Thrasivoulou, C., Underwood, C., Butler, P.E., and Cowen, T. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthritis Cartilage 13, 614, 2005.
98. Blanco, F.J., Rego, I., and Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 7, 161, 2011.
99. Davies, C.M., Guilak, F., Weinberg, J.B., and Fermor, B. Reactive nitrogen and oxygen species in interleukin-1- mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage 16, 624, 2008.
100. Yudoh, K., and Nishioka, K. Potential involvement of cellular senescence in the pathogenesis of bone and joint disease. Nihon Rinsho 63 Suppl 1, 719, 2005.
101. Nakagawa, S., Arai, Y., Mazda, O., Kishida, T., Takahashi, K.A., Sakao, K., Saito, M., Honjo, K., Imanishi, J., and Kubo, T. N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J Orthop Res 28, 156, 2010.
102. Whiteman, M., Dogra, Y., Winyard, P.G., and Armstrong, J.S. Detection and measurement of reactive oxygen intermediates in mitochondria and cells. Methods Mol Biol 476, 28, 2009.
103. Nagashima, T., DeArmond, S.J., Murovic, J., and Hoshino, T. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol 67, 155, 1985.
104. Johnson, H.A., Rubini, J.R., Cronkite, E.P., and Bond, V.P. Labeling of human tumor cells in vivo by tritiated thymidine. Lab Invest 9, 460, 1960.
105. Zeng, C., Pan, F., Jones, L.A., Lim, M.M., Griffin, E.A., Sheline, Y.I., Mintun, M.A., Holtzman, D.M., and Mach, R.H. Evaluation of 5-ethynyl-2'- deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res 1319, 21, 2010.
106. Gerdes, J., Lemke, H., Baisch, H., Wacker, H.H., Schwab, U., and Stein, H. Cell cycle analysis of a cell proliferationassociated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133, 1710, 1984.
107. Brown, D.C., and Gatter, K.C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17, 489, 1990.
108. Kurki, P., Ogata, K., and Tan, E.M. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 109, 49, 1988.
109. Robbins, B.A., de la Vega, D., Ogata, K., Tan, E.M., and Nakamura, R.M. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 111, 841, 1987.
110. Garcia, R.L., Coltrera, M.D., and Gown, A.M. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134, 733, 1989.
111. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J., and Sedivy, J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14, 501, 2004.
112. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre', M., Nuciforo, P.G., Bensimon, A., Maestro, R., Pelicci, P.G., and d'Adda di Fagagna, F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638, 2006.
113. Narita, M., Nunez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., and Lowe, S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703, 2003.
114. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P., and Jackson, S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194, 2003.
115. Takai, H., Smogorzewska, A., and de Lange, T. DNA damage foci at dysfunctional telomeres. Curr Biol 13, 1549, 2003.
116. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11, 1921, 1992.
117. Kolettas, E., Buluwela, L., Bayliss, M.T., and Muir, H.I. Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes. J Cell Sci 108 (Pt 5), 1991, 1995.
118. Fajkus, J., Simickova, M., and Malaska, J. Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology. Philos Trans R Soc Lond B Biol Sci 357, 545, 2002.
119. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321, 1999.
120. Kogler, G., Sensken, S., Airey, J.A., Trapp, T., Muschen, M., Feldhahn, N., Liedtke, S., Sorg, R.V., Fischer, J., Ro- senbaum, C., Greschat, S., Knipper, A., Bender, J., Degistirici, O., Gao, J., Caplan, A.I., Colletti, E.J., Almeida- Porada, G., Muller, H.W., Zanjani, E., and Wernet, P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200, 123, 2004.
121. Goodwin, H.S., Bicknese, A.R., Chien, S.N., Bogucki, B.D., Quinn, C.O., and Wall, D.A. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7, 581, 2001.
122. Kogler, G., Radke, T.F., Lefort, A., Sensken, S., Fischer, J., Sorg, R.V., and Wernet, P. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33, 573, 2005.
123. Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T., Dombkowski, D.M., Cheng, T., DePinho, R.A., Sharpless, N.E., and Scadden, D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421, 2006.
124. Bellosta, P., Masramon, L., Mansukhani, A., and Basilico, C. p21(WAF1/CIP1) acts as a brake in osteoblast differentiation. J Bone Miner Res 18, 818, 2003.
125. Funato, N., Ohtani, K., Ohyama, K., Kuroda, T., and Nakamura, M. Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol 21, 7416, 2001.
126. Naaz, A., Holsberger, D.R., Iwamoto, G.A., Nelson, A., Kiyokawa, H., and Cooke, P.S. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J 18, 1925, 2004.
127. Dai, S.M., Shan, Z.Z., Nakamura, H., Masuko-Hongo, K., Kato, T., Nishioka, K., and Yudoh, K. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 54, 818, 2006.
128. Krishnamurthy, J., Torrice, C., Ramsey, M.R., Kovalev, G.I., Al-Regaiey, K., Su, L., and Sharpless, N.E. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114, 1299, 2004.
129. Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P., and Campisi, J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22, 4212, 2003.
130. Itahana, K., Zou, Y., Itahana, Y., Martinez, J.L., Beausejour, C., Jacobs, J.J., Van Lohuizen, M., Band, V., Campisi, J., and Dimri, G.P. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 23, 389, 2003.
131. Gil, J., and Peters, G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7, 667, 2006.
132. Nilsson, O., Mitchum, R.D., Jr., Schrier, L., Ferns, S.P., Barnes, K.M., Troendle, J.F., and Baron, J. Growth plate senescence is associated with loss of DNA methylation. J Endocrinol 186, 241, 2005.
133. Poschl, E., Fidler, A., Schmidt, B., Kallipolitou, A., Schmid, E., and Aigner, T. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis 64, 477, 2005.
134. Roach, H.I., Yamada, N., Cheung, K.S., Tilley, S., Clarke, N.M., Oreffo, R.O., Kokubun, S., and Bronner, F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52, 3110, 2005.
135. Iliopoulos, D., Malizos, K.N., and Tsezou, A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66, 1616, 2007.
136. Jayani, R.S., Ramanujam, P.L., and Galande, S. Studying histone modifications and their genomic functions by employing chromatin immunoprecipitation and immunoblotting. Methods Cell Biol 98, 35, 2010.
137. Ammerpohl, O., Martin-Subero, J.I., Richter, J., Vater, I., and Siebert, R. Hunting for the 5th base: techniques for analyzing DNA methylation. Biochim Biophys Acta 1790, 847, 2009.
138. Brandl, A., Angele, P., Roll, C., Prantl, L., Kujat, R., and Kinner, B. Influence of the growth factors PDGF-BB, TGFbeta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J Orthop Res 28, 354, 2010.
139. Mizuta, H., Kudo, S., Nakamura, E., Otsuka, Y., Takagi, K., and Hiraki, Y. Active proliferation of mesenchymal cells prior to the chondrogenic repair response in rabbit fullthickness defects of articular cartilage. Osteoarthritis Cartilage 12, 586, 2004.
140. Solchaga, L.A., Penick, K., Porter, J.D., Goldberg, V.M., Caplan, A.I., and Welter, J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol 203, 398, 2005.
141. Ito, T., Sawada, R., Fujiwara, Y., Seyama, Y., and Tsuchiya, T. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 359, 108, 2007.
142. Blaney Davidson, E.N., Scharstuhl, A., Vitters, E.L., van der Kraan, P.M., and van den Berg, W.B. Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther 7, R1338, 2005.
143. Im, G.I., Jung, N.H., and Tae, S.K. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 12, 527, 2006.
144. Pei, M., He, F., Kish, V., and Vunjak-Novakovic, G. Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study. Clin Orthop Relat Res 466, 1880, 2008.
145. Zheng, S.X., Mouithys-Mickalad, A., Deby-Dupont, G.P., Deby, C.M., Maroulis, A.P., Labasse, A.H., Lamy, M.L., Crielaard, J.M., Reginster, J.Y., and Henrotin, Y.E. In vitro study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminol-dependent chemiluminescence produced by human chondrocytes. Osteoarthritis Cartilage 8, 419, 2000.
146. Muscari, C., Bonafe', F., Farruggia, G., Stanic, I., Gamberini, C., Carboni, M., Basile, I., Giordano, E., Caldarera, C.M., and Guarnieri, C. Long-term treatment with N-acetylcysteine, but not caloric restriction, protects mesenchymal stem cells of aged rats against tumor necrosis factorinduced death. Exp Gerontol 41, 800, 2006.
147. Yudoh, K., and Karasawa, R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging (Albany, NY) 2, 990, 2010.
148. Hardeland, R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27, 119, 2005.
149. Reiter, R.J., Acuna-Castroviejo, D., Tan, D.X., and Burkhardt, S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci 939, 200, 2001.
150. Pei, M., He, F., Wei, L., and Rawson, A. Melatonin enhances cartilage matrix synthesis by porcine articular chondrocytes. J Pineal Res 46, 181, 2009.
151. Yudoh, K., Shishido, K., Murayama, H., Yano, M., Matsubayashi, K., Takada, H., Nakamura, H., Masuko, K., Kato, T., and Nishioka, K. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum 56, 3307, 2007.
152. Shahdadfar, A., Fronsdal, K., Haug, T., Reinholt, F.P., and Brinchmann, J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357, 2005.
153. Giannoni, P., Pagano, A., Maggi, E., Arbico, R., Randazzo, N., Grandizio, M., Cancedda, R., and Dozin, B. Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 13, 589, 2005.
154. Johnson, W.E., Stephan, S., and Roberts, S. The influence of serum, glucose and oxygen on intervertebral disc cell growth in vitro: implications for degenerative disc disease. Arthritis Res Ther 10, R46, 2008.
155. Drengk, A., Zapf, A., Sturmer, E.K., Sturmer, K.M., and Frosch, K.H. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189, 317, 2009.
156. Mishra, A., Tummala, P., King, A., Lee, B., Kraus, M., Tse, V., and Jacobs, C.R. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15, 431, 2009.
157. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005.
158. Vogel, J.P., Szalay, K., Geiger, F., Kramer, M., Richter, W., and Kasten, P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 17, 462, 2006.
159. Lo, T., Ho, J.H., Yang, M.H., and Lee, O.K. Glucose reduction prevents replicative senescence and increases mitochondrial respiration in human mesenchymal stem cells. Cell Transplant 20, 813, 2011.
160. Moussavi-Harami, F., Duwayri, Y., Martin, J.A., Moussavi- Harami, F., and Buckwalter, J.A. Oxygen effects on senescence in chondrocytes and mesenchymal stem cells: consequences for tissue engineering. Iowa Orthop J 24, 15, 2004.
161. Jin, Y., Kato, T., Furu, M., Nasu, A., Kajita, Y., Mitsui, H., Ueda, M., Aoyama, T., Nakayama, T., Nakamura, T., and Toguchida, J. Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem Biophys Res Commun 391, 1471, 2010.
162. Schrobback, K., Klein, TJ., Crawford, R., Upton, Z., Malda, J., and Leavesley, D.I. Effects of oxygen and culture system on in vitro propagation and redifferentiation of osteoarthritic human articular chondrocytes. Cell Tissue Res 2011 [Epub ahead of print]; DOI:10.1007/s00441-011-1193-7.
163. Khan, W.S., Adesida, A.B., and Hardingham, T.E. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther 9, R55, 2007.
164. Li, J., and Pei, M. Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A 17, 703, 2011.
165. Tsai, C.C., Chen, Y.J., Yew, T.L., Chen, L.L., Wang, J.Y., Chiu, C.H., and Hung, S.C. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 117, 459, 2011.
166. Badylak, S.F., Vorp, D.A., Spievack, A.R., Simmons-Byrd, A., Hanke, J., Freytes, D.O., Thapa, A., Gilbert, T.W., and Nieponice, A. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 128, 87, 2005.
167. Bhrany, A.D., Beckstead, B.L., Lang, T.C., Farwell, D.G., Giachelli, C.M., and Ratner, B.D. Development of an esophagus acellular matrix tissue scaffold. Tissue Eng 12, 319, 2006.
168. Brown, B., Lindberg, K., Reing, J., Stolz, D.B., and Badylak, S.F. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 12, 519, 2006.
169. Badylak, S.F., Kochupura, P.V., Cohen, I.S., Doronin, S.V., Saltman, A.E., Gilbert, T.W., Kelly, D.J., Ignotz, R.A., and Gaudette, G.R. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 15 Suppl 1, S29, 2006.
170. Ponce Marquez, S., Martinez, V.S., McIntosh Ambrose, W., Wang, J., Gantxegui, N.G., Schein, O., and Elisseeff, J. Decellularization of bovine corneas for tissue engineering applications. Acta Biomater 5, 1839, 2009.
171. Atala, A., Vacanti, J.P., Peters, C.A., Mandell, J., Retik, A.B., and Freeman, M.R. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 148, 658, 1992.
172. Atala, A., Freeman, M.R., Vacanti, J.P., Shepard, J., and Retik, A.B. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 150, 608, 1993.
173. Dequach, J.A., Yuan, S.H., Goldstein, L.S., and Christman, K.L. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A 17, 2583, 2011.
174. Petersen, T.H., Calle, E.A., Zhao, L., Lee, E.J., Gui, L., Raredon, M.B., Gavrilov, K., Yi, T., Zhuang, Z.W., Breuer, C., Herzog, E., and Niklason, L.E. Tissue-engineered lungs for in vivo implantation. Science 329, 538, 2010.
175. Zhou, P., Lessa, N., Estrada, D.C., Severson, E.B., Lingala, S., Zern, M.A., Nolta, J.A., and Wu, J. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl 17, 418, 2011.
176. Choi, J.S., Kim, B.S., Kim, J.Y., Kim, J.D., Choi, Y.C., Yang, H.J., Park, K., Lee, H.Y., and Cho, Y.W. Decellularized ex- tracellular matrix derived from human adipose tissue as a potential scaffold for allograft tissue engineering. J Biomed Mater Res A 97, 292, 2011.
177. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., and Taylor, D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
178. Urist, M.R. The classic: a morphogenetic matrix for differentiation of bone tissue. Clin Orthop Relat Res 467, 3068, 2009.
179. Cheng, N.C., Estes, B.T., Awad, H.A., and Guilak, F. Chondrogenic differentiation of adipose-derived adult stem cells by a porous scaffold derived from native articular cartilage extracellular matrix. Tissue Eng Part A 15, 231, 2009.
180. Diekman, B.O., Rowland, C.R., Lennon, D.P., Caplan, A.I., and Guilak, F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A 16, 523, 2010.
181. Yang, Q., Peng, J., Guo, Q., Huang, J., Zhang, L., Yao, J., Yang, F., Wang, S., Xu, W., Wang, A., and Lu, S. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials 29, 2378, 2008.
182. Choi, K.H., Choi, B.H., Park, S.R., Kim, B.J., and Min, B.H. The chondrogenic differentiation of mesenchymal stem cells on an extracellular matrix scaffold derived from porcine chondrocytes. Biomaterials 31, 5355, 2010.
183. Cheng, H.W., Tsui, Y.K., Cheung, K.M., Chan, D., and Chan, B.P. Decellularization of chondrocyte-encapsulated collagen microspheres: a three-dimensional model to study the effects of acellular matrix on stem cell fate. Tissue Eng Part C Methods 15, 697, 2009.
184. Pei, M., He, F., and Wei, L. Three-dimensional cell expansion substrate for cartilage tissue engineering and regeneration: a comparision in decellularized matrix deposited by synovium-derived stem cells and chondrocytes. J Tissue Sci Eng 2, 104, 2011.
185. Pei, M., Li, J.T., Shoukry, M., and David, T. A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering. Eur Cell Mater 22, 333, 2011.
186. He, F., Chen, X., and Pei, M. Reconstruction of an in vitro tissue-specific microenvironment to rejuvenate synoviumderived stem cells for cartilage tissue engineering. Tissue Eng Part A 15, 3809, 2009.
187. He, F., and Pei, M Extracellular matrix enhances differentiation of adipose stem cells from infrapatellar fat pad toward chondrogenesis. J Tissue Eng Regen Med 2011 [Epub ahead of print]; DOI: 10.1002/term.505.
188. Pei, M., He, F., and Kish, V. Expansion on extracellular matrix deposited by human bone marrow stromal cells facilitates stem cell proliferation and tissue-specific lineage potential. Tissue Eng Part A 17, 3067, 2011.
189. Pei, M., and He, F. Extracellular matrix deposited by synovium- derived stem cells delays replicative senescent chondrocyte dedifferentiation and enhances redifferentiation. J Cell Physiol 227, 2163, 2012.
190. He, F., and Pei, M Rejuvenation of nucleus pulposus cells using extracellular matrix deposited by synovium-derived stem cells. Spine (Phila Pa 1976) 2011 [Epub ahead of print]; DOI: 10.1097/BRS.0b013e31821fcc64.
191. Choi, H.R., Cho, K.A., Kang, H.T., Lee, J.B., Kaeberlein, M., Suh, Y., Chung, I.K., and Park, S.C. Restoration of senescent human diploid fibroblasts by modulation of the extracellular matrix. Aging Cell 10, 148, 2011.
192. Sun, Y., Li, W., Lu, Z., Chen, R., Ling, J., Ran, Q., Jilka, R.L., and Chen, X.D. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J 25, 1474, 2011.
193. Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. Notch signaling: cell fate control and signal integration in development. Science 284, 770, 1999.
194. Watanabe, N., Tezuka, Y., Matsuno, K., Miyatani, S., Morimura, N., Yasuda, M., Fujimaki, R., Kuroda, K., Hiraki, Y., Hozumi, N., and Tezuka, K. Suppression of differentiation and proliferation of early chondrogenic cells by Notch. J Bone Miner Metab 21, 344, 2003.
195. Grogan, S.P., Olee, T., Hiraoka, K., and Lotz, M.K. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum 58, 2754, 2008.
196. Maruyama, T., Mirando, A.J., Deng, C.X., and Hsu, W. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 3, ra40, 2010.
197. Hayward, P., Kalmar, T., and Arias, A.M. Wnt/Notch signalling and information processing during development. Development 135, 411, 2008.
198. Kennell, J.A., and MacDougald, O.A. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J Biol Chem 280, 24004, 2005.
199. Cawthorn, W.P., Heyd, F., Hegyi, K., and Sethi, J.K. Tumour necrosis factor-alpha inhibits adipogenesis via a betacatenin/ TCF4(TCF7L2)-dependent pathway. Cell Death Differ 14, 1361, 2007.
200. Hyun Hwa, C., Hye Joon, J., Ji Sun, S., Yong Chan, B., and Jin Sup, J. Crossregulation of beta-catenin/Tcf pathway by NF-kappaB is mediated by lzts2 in human adipose tissuederived mesenchymal stem cells. Biochim Biophys Acta 1783, 419, 2008.
201. Zhang, D.Y., Wang, H.J., and Tan, Y.Z. Wnt/beta-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One 6, e21397, 2011.
202. Park, J.S., Kim, H.Y., Kim, H.W., Chae, G.N., Oh, H.T., Park, J.Y., Shim, H., Seo, M., Shin, E.Y., Kim, E.G., Park, S.C., and Kwak, S.J. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev 126, 551, 2005.
203. Shibata, K.R., Aoyama, T., Shima, Y., Fukiage, K., Otsuka, S., Furu, M., Kohno, Y., Ito, K., Fujibayashi, S., Neo, M., Nakayama, T., Nakamura, T., and Toguchida, J. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25, 2371, 2007.
204. Abreu, J.G., Ketpura, N.I., Reversade, B., and De Robertis, E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4, 599, 2002.
205. Katsuki, Y., Sakamoto, K., Minamizato, T., Makino, H., Umezawa, A., Ikeda, M.A., Perbal, B., Amagasa, T., Yamaguchi, A., and Katsube, K. Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1. Biochem Biophys Res Commun 368, 808, 2008.
206. Si, W., Kang, Q., Luu, H.H., Park, J.K., Luo, Q., Song, W.X., Jiang, W., Luo, X., Li, X., Yin, H., Montag, A.G., Haydon, R.C., and He, T.C. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3Ainduced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26, 2955, 2006.
207. Schutze, N., Noth, U., Schneidereit, J., Hendrich, C., and Jakob, F. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal 3, 5, 2005.
208. Luo, Q., Kang, Q., Si, W., Jiang, W., Park, J.K., Peng, Y., Li, X., Luu, H.H., Luo, J., Montag, A.G., Haydon, R.C., and He, T.C. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279, 55958, 2004.
209. Maeda, A., Nishida, T., Aoyama, E., Kubota, S., Lyons, K.M., Kuboki, T., and Takigawa, M. CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145, 207, 2009.
210. Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R., and Smith, J.C. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131, 2137, 2004.
211. Woods, A., Pala, D., Kennedy, L., McLean, S., Rockel, J.S., Wang, G., Leask, A., and Beier, F. Rac1 signaling regulates CTGF/CCN2 gene expression via TGFbeta/Smad signaling in chondrocytes. Osteoarthritis Cartilage 17, 406, 2009.
212. Kawaki, H., Kubota, S., Suzuki, A., Lazar, N., Yamada, T., Matsumura, T., Ohgawara, T., Maeda, T., Perbal, B., Lyons, K.M., and Takigawa, M. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res 23, 1751, 2008.
213. Pennica, D., Swanson, T.A., Welsh, J.W., Roy, M.A., Lawrence, D.A., Lee, J., Brush, J., Taneyhill, L.A., Deuel, B., Lew, M., Watanabe, C., Cohen, R.L., Melhem, M.F., Finley, G.G., Quirke, P., Goddard, A.D., Hillan, K.J., Gurney, A.L., Botstein, D., and Levine, A.J. WISP genes are members of the connective tissue growth factor family that are upregulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95, 14717, 1998.
214. French, D.M., Kaul, R.J., D'Souza, A.L., Crowley, C.W., Bao, M., Frantz, G.D., Filvaroff, E.H., and Desnoyers, L. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165, 855, 2004.
215. Zushi, S., Akagi, M., Kishimoto, H., Teramura, T., Sawamura, T., and Hamanishi, C. Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1. Arthritis Rheum 60, 3007, 2009.
216. Yudoh, K., Shi, Y., and Karasawa, R. Angiogenic growth factors inhibit chondrocyte ageing in osteoarthritis: potential involvement of catabolic stress-induced overexpression of caveolin-1 in cellular ageing. Int J Rheum Dis 12, 90, 2009.
217. Krejci, P., Prochazkova, J., Smutny, J., Chlebova, K., Lin, P., Aklian, A., Bryja, V., Kozubik, A., and Wilcox, W.R. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone 47, 102, 2010.
218. Iwasaki, M., Nakata, K., Nakahara, H., Nakase, T., Kimura, T., Kimata, K., Caplan, A.I., and Ono, K. Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteumderived cells. Endocrinology 132, 1603, 1993.
219. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., and Pittenger, M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4, 415, 1998.
220. Blaney Davidson, E.N., Remst, D.F., Vitters, E.L., van Beuningen, H.M., Blom, A.B., Goumans, M.J., van den Berg, W.B., and van der Kraan, P.M. Increase in ALK1/ ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 182, 7937, 2009.
221. Martel-Pelletier, J., Di Battista, J.A., Lajeunesse, D., and Pelletier, J.P. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47, 90, 1998.
222. Cristofalo, V.J., Phillips, P.D., Sorger, T., and Gerhard, G. Alterations in the responsiveness of senescent cells to growth factors. J Gerontol 44, 55, 1989.
223. Ceda, G.P., Dall'Aglio, E., Maggio, M., Lauretani, F., Bandinelli, S., Falzoi, C., Grimaldi, W., Ceresini, G., Corradi, F., Ferrucci, L., Valenti, G., and Hoffman, A.R. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 28, 96, 2005.
224. Anversa, P. Aging and longevity: the IGF-1 enigma. Circ Res 97, 411, 2005.
225. Okuda, S., Myoui, A., Ariga, K., Nakase, T., Yonenobu, K., and Yoshikawa, H. Mechanisms of age-related decline in insulin-like growth factor-I dependent proteoglycan synthesis in rat intervertebral disc cells. Spine (Phila Pa 1976) 26, 2421, 2001.
226. D'avis, P.Y., Frazier, C.R., Shapiro, J.R., and Fedarko, N.S. Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells. Biochem J 324 (Pt 3), 753, 1997.
227. Cao, J.J., Kurimoto, P., Boudignon, B., Rosen, C., Lima, F., and Halloran, B.P. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J Bone Miner Res 22, 1271, 2007.
228. Martin, J.A., Ellerbroek, S.M., and Buckwalter, J.A. Agerelated decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res 15, 491, 1997.
229. Loeser, R.F., Shanker, G., Carlson, C.S., Gardin, J.F., Shelton, B.J., and Sonntag, W.E. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43, 2110, 2000.
230. Messai, H., Duchossoy, Y., Khatib, A.M., Panasyuk, A., and Mitrovic, D.R. Articular chondrocytes from aging rats respond poorly to insulin-like growth factor-1: an altered signaling pathway. Mech Ageing Dev 115, 21, 2000.
231. Boehm, A.K., Seth, M., Mayr, K.G., and Fortier, L.A. Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Arthritis Rheum 56, 2335, 2007.
232. Fortier, L.A., and Miller, B.J. Signaling through the small Gprotein Cdc42 is involved in insulin-like growth factor-I resistance in aging articular chondrocytes. J Orthop Res 24, 1765, 2006.
233. Schwartz, M. Rho signalling at a glance. J Cell Sci 117, 5457, 2004.
234. Welniak, L.A., Karas, M., Yakar, S., Anver, M.R., Murphy, W.J., and LeRoith, D. Effects of organ-specific loss of insulin- like growth factor-I production on murine hematopoiesis. Biol Blood Marrow Transplant 10, 32, 2004.
235. Gibson, L.F., Piktel, D., and Landreth, K.S. Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82, 3005, 1993.
236. Kalluri, H.S., and Dempsey, R.J. IGFBP-3 inhibits the proliferation of neural progenitor cells. Neurochem Res 36, 406, 2011.
237. Miura, T., Mattson, M.P., and Rao, M.S. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3, 333, 2004.
238. An, C., Cheng, Y., Yuan, Q., and Li, J. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng 38, 1647, 2010.
239. Wang, L., and Detamore, M.S. Insulin-like growth factor-I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells. J Orthop Res 27, 1109, 2009.
240. Fukumoto, T., Sperling, J.W., Sanyal, A., Fitzsimmons, J.S., Reinholz, G.G., Conover, C.A., and O'Driscoll, S.W. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 11, 55, 2003.
241. Mierisch, C.M., Anderson, P.C., Balian, G., and Diduch, D.R. Treatment with insulin-like growth factor-1 increases chondrogenesis by periosteum in vitro. Connect Tissue Res 43, 559, 2002.
242. Sakimura, K., Matsumoto, T., Miyamoto, C., Osaki, M., and Shindo, H. Effects of insulin-like growth factor I on transforming growth factor beta1 induced chondrogenesis of synovium- derived mesenchymal stem cells cultured in a polyglycolic acid scaffold. Cells Tissues Organs 183, 55, 2006.
243. Longobardi, L., O'Rear, L., Aakula, S., Johnstone, B., Shimer, K., Chytil, A., Horton, W.A., Moses, H.L., and Spagnoli, A. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21, 626, 2006.
244. Worster, A.A., Brower-Toland, B.D., Fortier, L.A., Bent, S.J., Williams, J., and Nixon, A.J. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19, 738, 2001.
245. Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S., and Schreiber, S.L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756, 1994.
246. Martin, D.E., and Hall, M.N. The expanding TOR signaling network. Curr Opin Cell Biol 17, 158, 2005.
247. Rokutanda, S., Fujita, T., Kanatani, N., Yoshida, C.A., Komori, H., Liu, W., Mizuno, A., and Komori, T. Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol 328, 78, 2009.
248. Gagarina, V., Gabay, O., Dvir-Ginzberg, M., Lee, E.J., Brady, J.K., Quon, M.J., and Hall, D.J. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 62, 1383, 2010.
249. Qureshi, H.Y., Ahmad, R., Sylvester, J., and Zafarullah, M. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases- 3 gene expression by TGF-beta in human chondrocytes. Cell Signal 19, 1643, 2007.
250. Starkman, B.G., Cravero, J.D., Delcarlo, M., and Loeser, R.F. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem J 389, 723, 2005.
251. Phornphutkul, C., Wu, K.Y., Auyeung, V., Chen, Q., and Gruppuso, P.A. mTOR signaling contributes to chondrocyte differentiation. Dev Dyn 237, 702, 2008.
252. Krampera, M., Pasini, A., Rigo, A., Scupoli, M.T., Tecchio, C., Malpeli, G., Scarpa, A., Dazzi, F., Pizzolo, G., and Vinante, F. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106, 59, 2005.
253. Hwa Cho, H., Bae, Y.C., and Jung, J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 24, 2744, 2006.
254. Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso- Noori, L., Zanin-Zhorov, A., Cohen, S., Cohen, I.R., and Zipori, D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 1422, 2007.
255. Tomchuck, S.L., Zwezdaryk, K.J., Coffelt, S.B., Waterman, R.S., Danka, E.S., and Scandurro, A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99, 2008.
256. Kim, H.S., Shin, T.H., Yang, S.R., Seo, M.S., Kim, D.J., Kang, S.K., Park, J.H., and Kang, K.S. Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One 5, e15369, 2010.